Table 1. Major characteristics of 14... | American Society of Hematology

Table 1.

Major characteristics of 14 HIV-infected patients with MCD who developed NHL

Patient	At MCD diagnosis		At NHL diagnosis
Patient	CD4⁺ T cells (× 10⁶/L)	HIV-RNA (copies/mL)	Delay for NHL (mo)	Antiretroviral therapy	CD4⁺ T cells (× 10⁶/L)	HIV-RNA (copies/mL)	KS
1	104	ND	5	—	64	ND	Yes
2	216	ND	2	—	216	ND	Yes
3	30	1 599 000	3	d4T-3TC-NVP	64	2 500	Yes
4	125	ND	76	d4T-3TC-RTV	280	334 000	No
5	373	255 000	23	AZT-3TC-IDV	688	< 500	No
6	1126	362 000	0	—	1126	362 000	No
7	68	5 300	18	ABC-ddI-RTV-SQV	114	< 50	No
8	171	230 000	60	AZT-3TC-RTV-SQV	887	< 20	Yes
9	144	ND	69	d4T-3TC-NFV-NVP	800	400	No
10	119	ND	7	—	8	ND	Yes
11	227	ND	23	—	410	ND	Yes
12	27	ND	6	d4T-3TC-IDV	ND	< 50	Yes
13	89	16 700	6	AZT-3TC-RTV-SQV	348	< 500	Yes
14	267	650 200	2	—	75	650 200	Yes

Patient	At MCD diagnosis		At NHL diagnosis
Patient	CD4⁺ T cells (× 10⁶/L)	HIV-RNA (copies/mL)	Delay for NHL (mo)	Antiretroviral therapy	CD4⁺ T cells (× 10⁶/L)	HIV-RNA (copies/mL)	KS
1	104	ND	5	—	64	ND	Yes
2	216	ND	2	—	216	ND	Yes
3	30	1 599 000	3	d4T-3TC-NVP	64	2 500	Yes
4	125	ND	76	d4T-3TC-RTV	280	334 000	No
5	373	255 000	23	AZT-3TC-IDV	688	< 500	No
6	1126	362 000	0	—	1126	362 000	No
7	68	5 300	18	ABC-ddI-RTV-SQV	114	< 50	No
8	171	230 000	60	AZT-3TC-RTV-SQV	887	< 20	Yes
9	144	ND	69	d4T-3TC-NFV-NVP	800	400	No
10	119	ND	7	—	8	ND	Yes
11	227	ND	23	—	410	ND	Yes
12	27	ND	6	d4T-3TC-IDV	ND	< 50	Yes
13	89	16 700	6	AZT-3TC-RTV-SQV	348	< 500	Yes
14	267	650 200	2	—	75	650 200	Yes

KS indicates Kaposi sarcoma; d4T, stavudine; 3TC, lamivudine; NFV, nelfinavir; NVP, nevirapine; RTV, ritonavir; AZT, zidovudine; IDV, indinavir; ABC, abacavir; ddI, didanosine; SQV, saquinavir; and ND, not determined.

View Large

This Feature Is Available To Subscribers Only